Persistent Generalized Weakness After Electrolyte Correction in Elderly Patients

The American College of Cardiology suggests that gabapentin can cause generalized weakness, fatigue, and sedation, particularly in elderly patients with renal impairment or those on higher doses 1, 2
The American College of Cardiology recommends verifying current gabapentin dosing is appropriate for age and renal function, with doses adjusted downward in elderly patients and those with any degree of renal insufficiency 1
Buspirone can cause fatigue, weakness, and sedation as common side effects, according to the American College of Cardiology 1
The combination of gabapentin plus buspirone may have additive sedating effects in elderly patients, as noted by the American College of Cardiology 2

Incomplete Electrolyte Correction

The Genetics in Medicine journal recommends confirming that sodium and magnesium are truly normalized and stable, and checking for ongoing losses by assessing for renal tubular dysfunction 3
Measuring serum calcium and phosphate is necessary, as hypomagnesemia often coexists with hypocalcemia and hypophosphatemia, all of which cause weakness, according to the Genetics in Medicine journal 3
Obtaining urine electrolytes to assess for renal losses if serum levels remain borderline or unstable is recommended by the Genetics in Medicine journal 3
Even after correction, patients may have residual weakness for days to weeks, particularly if hyponatremia was chronic, as noted by the Genetics in Medicine journal 3

The Journal of Clinical Oncology suggests checking HbA1c and fasting glucose to rule out impaired glucose metabolism as a cause of neuropathy 4
Chronic inflammatory demyelinating polyneuropathy (CIDP) requires nerve conduction studies and EMG for diagnosis, and can cause profound weakness beyond sensory symptoms, according to the Journal of Clinical Oncology 4
Monoclonal gammopathy can cause neuropathy and systemic symptoms, and obtaining serum protein electrophoresis with immunofixation is recommended by the Journal of the National Comprehensive Cancer Network 5, 6

Idiopathic neuropathy can involve autonomic nerves, causing orthostatic hypotension that manifests as weakness and fatigue, according to the American College of Cardiology 1, 2
Checking orthostatic vital signs (blood pressure and heart rate supine and after 3 minutes standing) is recommended by the Journal of Clinical Oncology and the American College of Cardiology 2, 4

Elderly patients experience rapid muscle deconditioning during acute illness, particularly with electrolyte disturbances, as noted by the American College of Cardiology 1, 2
Recovery of strength may take weeks even after biochemical correction, according to the Genetics in Medicine journal 3
Physical therapy assessment is warranted to distinguish deconditioning from ongoing pathology, as recommended by the American College of Cardiology 2

The Genetics in Medicine journal warns against assuming electrolytes are "corrected" based on a single normal value, and recommends verifying stability over several days and ruling out ongoing losses 3
The American College of Cardiology advises against overlooking gabapentin as a cause of weakness in elderly patients, as this is a commonly missed iatrogenic contributor 1, 2
The Journal of Clinical Oncology recommends not missing CIDP, which requires immunotherapy rather than symptomatic treatment and can cause severe, progressive weakness 4

The American College of Cardiology recommends reducing or temporarily discontinuing gabapentin to assess for improvement in weakness 1, 2
Verifying electrolytes are stable with repeat testing in 24-48 hours is recommended by the Genetics in Medicine journal 3
Obtaining comprehensive metabolic panel including calcium, phosphate, and renal function is suggested by the Genetics in Medicine journal 3
Checking orthostatic vital signs is recommended by the American College of Cardiology 2
Considering neurology referral for electrodiagnostic studies if weakness persists or progresses is advised by the Journal of Clinical Oncology 4